Literature DB >> 19864393

Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function.

Eric Bergeron1, César G Albariño, Marina L Khristova, Stuart T Nichol.   

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is a tick-borne virus (genus Nairovirus, family Bunyaviridae) associated with high case fatality disease outbreaks in regions of Africa, Europe, and Asia. The CCHFV genome consists of three negative-strand RNA segments, S, M, and L. The unusually large virus L polymerase protein and the need for biosafety level 4 (BSL-4) containment conditions for work with infectious virus have hampered the study of CCHFV replication. The L protein has an ovarian tumor (OTU) protease domain located in the N terminus, which has led to speculation that the protein may be autoproteolytically cleaved to generate the active virus L polymerase and additional functions. We report the successful development of efficient CCHFV helper virus-independent S, M, and L segment minigenome systems for analysis of virus RNA and protein features involved in replication. The virus RNA segment S, M, and L untranslated regions were found to be similar in support of replication of the respective minigenomes. In addition, the OTU domain located in the N terminus of the expressed virus L protein was shown to be a functional protease. However, no evidence of L protein autoproteolytic processing was found, and the OTU protease activity was dispensable for virus RNA replication. Finally, physiologically relevant doses of ribavirin inhibited CCHFV minigenome replication. These results demonstrated the utility of the minigenome system for use in BSL-2 laboratory settings to analyze CCHFV biology and in antiviral drug discovery programs for this important public health and bioterrorism threat.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19864393      PMCID: PMC2798392          DOI: 10.1128/JVI.01859-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Replicon system for Lassa virus.

Authors:  Meike Hass; Uta Gölnitz; Stefanie Müller; Beate Becker-Ziaja; Stephan Günther
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

2.  Efficient bunyavirus rescue from cloned cDNA.

Authors:  Anice C Lowen; Carol Noonan; Angela McLees; Richard M Elliott
Journal:  Virology       Date:  2004-12-20       Impact factor: 3.616

Review 3.  The role of reverse genetics systems in studying viral hemorrhagic fevers.

Authors:  Hideki Ebihara; Allison Groseth; Gabriele Neumann; Yoshihiro Kawaoka; Heinz Feldmann
Journal:  Thromb Haemost       Date:  2005-08       Impact factor: 5.249

4.  T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus.

Authors:  Matthias Habjan; Nicola Penski; Martin Spiegel; Friedemann Weber
Journal:  J Gen Virol       Date:  2008-09       Impact factor: 3.891

5.  Large RNA segment of Dugbe nairovirus encodes the putative RNA polymerase.

Authors:  A C Marriott; P A Nuttall
Journal:  J Gen Virol       Date:  1996-08       Impact factor: 3.891

6.  Role of the conserved nucleotide mismatch within 3'- and 5'-terminal regions of Bunyamwera virus in signaling transcription.

Authors:  John N Barr; Gail W Wertz
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

7.  Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs.

Authors:  Gjon Blakqori; Friedemann Weber
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

8.  Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.

Authors:  Alex Kentsis; Ivan Topisirovic; Biljana Culjkovic; Ling Shao; Katherine L B Borden
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

Review 9.  Metabolism and antiviral activity of ribavirin.

Authors:  William B Parker
Journal:  Virus Res       Date:  2005-02       Impact factor: 3.303

10.  A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae.

Authors:  Lisa M Kattenhorn; Gregory A Korbel; Benedikt M Kessler; Eric Spooner; Hidde L Ploegh
Journal:  Mol Cell       Date:  2005-08-19       Impact factor: 17.970

View more
  48 in total

1.  Arterivirus and nairovirus ovarian tumor domain-containing Deubiquitinases target activated RIG-I to control innate immune signaling.

Authors:  Puck B van Kasteren; Corrine Beugeling; Dennis K Ninaber; Natalia Frias-Staheli; Sander van Boheemen; Adolfo García-Sastre; Eric J Snijder; Marjolein Kikkert
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Structure, function, and evolution of the Crimean-Congo hemorrhagic fever virus nucleocapsid protein.

Authors:  Stephen D Carter; Rebecca Surtees; Cheryl T Walter; Antonio Ariza; Éric Bergeron; Stuart T Nichol; Julian A Hiscox; Thomas A Edwards; John N Barr
Journal:  J Virol       Date:  2012-08-08       Impact factor: 5.103

3.  A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.

Authors:  Stephanie Devignot; Eric Bergeron; Stuart Nichol; Ali Mirazimi; Friedemann Weber
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

4.  Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth.

Authors:  Éric Bergeron; Ayan K Chakrabarti; Brian H Bird; Kim A Dodd; Laura K McMullan; Christina F Spiropoulou; Stuart T Nichol; César G Albariño
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

5.  Diversity of ubiquitin and ISG15 specificity among nairoviruses' viral ovarian tumor domain proteases.

Authors:  Glenn C Capodagli; Michelle K Deaton; Erica A Baker; Ryan J Lumpkin; Scott D Pegan
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

6.  Deubiquitinase function of arterivirus papain-like protease 2 suppresses the innate immune response in infected host cells.

Authors:  Puck B van Kasteren; Ben A Bailey-Elkin; Terrence W James; Dennis K Ninaber; Corrine Beugeling; Mazdak Khajehpour; Eric J Snijder; Brian L Mark; Marjolein Kikkert
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-11       Impact factor: 11.205

Review 7.  Mechanisms for regulating deubiquitinating enzymes.

Authors:  Cynthia Wolberger
Journal:  Protein Sci       Date:  2014-02-12       Impact factor: 6.725

8.  Biochemical and Structural Insights into the Preference of Nairoviral DeISGylases for Interferon-Stimulated Gene Product 15 Originating from Certain Species.

Authors:  M K Deaton; J V Dzimianski; C M Daczkowski; G K Whitney; N J Mank; M M Parham; E Bergeron; S D Pegan
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

9.  Identification of 2'-deoxy-2'-fluorocytidine as a potent inhibitor of Crimean-Congo hemorrhagic fever virus replication using a recombinant fluorescent reporter virus.

Authors:  Stephen R Welch; Florine E M Scholte; Mike Flint; Payel Chatterjee; Stuart T Nichol; Éric Bergeron; Christina F Spiropoulou
Journal:  Antiviral Res       Date:  2017-10-09       Impact factor: 5.970

10.  Fluorometric CCHFV OTU protease assay with potent inhibitors.

Authors:  Fatih Kocabas; Galip S Aslan
Journal:  Virus Genes       Date:  2015-07-09       Impact factor: 2.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.